Study: Donanemab Significantly Reduces Cognitive, Functional Decline Associated With Alzheimer Disease – Pharmacy Times

by

  1. Study: Donanemab Significantly Reduces Cognitive, Functional Decline Associated With Alzheimer Disease Pharmacy Times
  2. Alzheimer’s patient: New ‘miracle’ drug has ‘given me my life back’ New York Post
  3. New Alzheimer’s treatment: Donanemab drug seen as turning point in fight against disease FRANCE 24 English
  4. Eli Lilly says FDA approval of Alzheimer’s drug donanemab could come later this year Fox Business
  5. More developments being made in Alzheimer’s research WBAL-TV 11 Baltimore
  6. View Full Coverage on Google News

Read original article here

Leave a Comment